SFShinji Furuya

Shinji Furuya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shinji Furuya has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prognostic Significance of Serum Tumor Markers According to the Timing of Recurrence After Curative Esophagectomy for Esophageal Squamous Cell Carcinoma

    by Akihito Mizukami, Suguru Maruyama, Katsutoshi Shoda, Yoshihiko Kawaguchi, Yuto Saegusa, Taishu Oka, Takaomi Ozawa, Hiroto Tanaka, Ryo Saito, Wataru Izumo, et al.

    Background: Reliable biomarkers for predicting post‐recurrence survival in esophageal squamous cell carcinoma (ESCC) remain limited. We evaluated the prognostic significance of three serum tumor markers routinely used in clinical practice (carcinoembryonic antigen [CEA], squamous cell carcinoma antigen [SCC], and serum p53 antibody [p53‐Ab]) in patients with recurrent ESCC after curative esophagectomy. Methods: Sixty patients who developed recurrence after curative resection for ESCC were retrospectively analyzed. Overall survival (OS) after recurrence was compared according to serum CEA, SCC, and p53‐Ab levels measured at recurrence. Exploratory subgroup analyses were performed according to the timing of recurrence. Results: Elevated SCC levels at recurrence were significantly associated with worse post‐recurrence OS ( p < 0.01), whereas CEA and p53‐Ab levels were not. Multivariable analysis identified elevated SCC as an independent predictor of poor post‐recurrence survival (hazard ratio, 2.50; 95% confidence interval, 1.18–5.33; p = 0.02). In the exploratory analysis according to recurrence timing, elevated SCC levels were associated with worse survival among patients with standard recurrence ( p < 0.01), whereas no significant associations were observed for CEA or p53‐Ab. Among patients with late recurrence, elevated p53‐Ab levels showed a possible association with poorer survival ( p = 0.05). Conclusions: Serum SCC measured at recurrence may serve as a prognostic biomarker for post‐recurrence survival in patients with ESCC after curative esophagectomy. Exploratory analyses according to recurrence timing suggested that SCC may be particularly relevant in standard recurrence, whereas p53‐Ab showed a possible prognostic association in late recurrence.

  • Open Access

    Rectovesical Fistula Caused by a Self‐Inserted Intravesical Foreign Body Immobilized by a Giant Vesical Calculus: A Case Report

    by Koshiro Hikawa, Takanori Mochizuki, Fumiakira Yano, Shinji Furuya, Kazunori Takahashi, Keiichiro Hirose, Hiroshi Shimura, Satoru Kira, Norifumi Sawada, Takahiko Mitsui

    Introduction: Intravesical foreign bodies may remain silent until secondary complications occur. Rectovesical fistula caused by an intravesical foreign body is rare. Case Presentation: A 69‐year‐old man presented with urinary frequency and abdominal distension. Computed tomography revealed a 70.8‐mm vesical calculus encasing an approximately 8‐cm plastic object, with bilateral hydroureteronephrosis and suspected rectal involvement. Cystoscopic evaluation was limited by the massive calculus. Intravesical indigo carmine appeared from the rectum, and colonoscopy confirmed a foreign body protruding through the anterior rectal wall. Open cystotomy with removal of the foreign body and fragmented adherent stone, suprapubic cystostomy, and diverting transverse colostomy were performed. Delayed laparoscopic fistula closure and subsequent stoma closure were completed. Hydroureteronephrosis and renal function improved, with no recurrence. Conclusion: A long‐retained intravesical foreign body can cause rectovesical fistula through stone‐mediated fixation. Staged management may be appropriate when inflammation and contamination preclude immediate closure.

  • Evolution of Pancreatic Transection Strategy in Minimally Invasive Distal Pancreatectomy

    by Ryo Saito, Hidetake Amemiya, Wataru Izumo, Taishu Oka, Suguru Maruyama, Koichi Takiguchi, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Yoshihiko Kawaguchi, et al.

    Background: Clinically relevant postoperative pancreatic fistula (CR‐POPF) remains a major complication after distal pancreatectomy (DP), including minimally invasive distal pancreatectomy (MIDP). Institutions often introduce multiple technical and perioperative refinements over time; however, the cumulative impact of these practice changes on postoperative outcomes has not been fully characterized. This study evaluated whether stepwise institutional refinements in MIDP were associated with improved postoperative outcomes. Methods: We retrospectively analyzed 124 consecutive patients who underwent MIDP between 2019 and 2025 at a single center. During the study period, several practice changes were implemented, including modification of pancreatic transection strategy using a reinforced stapler platform, transition to robotic assistance, and adoption of continuous negative‐pressure drainage. The cohort was divided into an early phase and a late phase reflecting these institutional refinements. The primary outcome was CR‐POPF, and secondary outcomes included drain fluid amylase (DFA) levels and postoperative length of stay (LOS). Propensity score matching (PSM) was performed using pancreatic thickness and texture. Results: CR‐POPF occurred less frequently in the late phase than in the early phase (5.3% vs. 24.4%, p = 0.012). DFA levels were consistently lower and declined more rapidly in the late phase. LOS was significantly shorter in the late phase (median 8 vs. 11 days, p < 0.001). These findings remained consistent after PSM. Conclusion: Stepwise institutional refinements in pancreatic transection technique and perioperative management were associated with improved postoperative outcomes after MIDP. A structured quality‐improvement approach focusing on atraumatic transection and rational drain management may contribute to reducing CR‐POPF after MIDP.

  • Open Access

    To Evaluate Whether Pretreatment CA19 ‐9 and DUPAN ‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer

    by Hiromichi Kawaida, Wataru Izumo, Ryo Saito, Hidetake Amemiya, Suguru Maruyama, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Yoshihiko Kawaguchi, Daisuke Ichikawa

    Aim: Pancreatic cancer (PC) remains one of the most lethal malignancies, with early recurrence severely affecting prognosis even after curative resection. While neoadjuvant treatments (NAT), such as gemcitabine plus S‐1 (NAT‐GS), have improved outcomes, predicting their effectiveness and optimizing patient selection remain challenging. This study aimed to investigate whether pretreatment CA19‐9 and DUPAN‐2 levels can serve as predictive markers to guide the choice between NAT and upfront surgery in pancreatic cancer. Methods: We retrospectively analyzed 190 patients with PC (67 with NAT‐GS and 123 with upfront surgery). Patients were stratified into three groups based on their pre‐NAT CA19‐9/DUPAN‐2 levels: both within the reference range, one exceeding, or both exceeding. The 12 month recurrence‐free survival (12MRFS) rates were assessed using the Kaplan–Meier method, with log‐rank and other appropriate statistical tests for comparison. Results: NAT‐GS was significantly more effective only in patients with one tumor marker above the reference range, comparing those who achieved 12 month MRFS with those who did not. In the Kaplan–Meier curve, among patients with only one elevated tumor marker, the NAT‐GS group showed a significantly better 12MRFS ratio than the upfront surgery group (78.6% vs. 51.2%, p = 0.034). Conclusion: The combination of pre‐NAT CA19‐9 and DUPAN‐2 levels may serve as a useful criterion for selecting between upfront surgery, NAT‐GS, or more intensive chemotherapy. This suggests the possibility of a tailored approach, in which a combination of tumor markers would determine whether to opt for upfront surgery, NAT‐GS, or more intensive chemotherapy.

  • Open Access

    Impact of Circular Stapler Size on Short‐Term Outcomes and Long‐Term Quality of Life After McKeown Esophagectomy

    by Suguru Maruyama, Katsutoshi Shoda, Yoshihiko Kawaguchi, Ryo Saito, Wataru Izumo, Kensuke Shiraishi, Shinji Furuya, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

    Background: The circular stapling technique (CST) is reported to be a simple and time‐efficient method; however, it is associated with a high incidence of anastomotic stenosis for McKeown esophagectomy. Meanwhile, the impact of circular stapler size remains controversial. We aimed to investigate the impact of circular stapler size on both short‐term outcomes and long‐term quality of life (QOL) after McKeown esophagectomy. Methods: In total, 63 consecutive patients who underwent McKeown esophagectomy for esophageal cancer between 2019 and 2022 were eligible. We examined the association between circular stapler size and short‐term outcomes and long‐term QOL using the PGSAS‐37. Results: 35 (55.6%) patients underwent anastomosis with a 21 mm stapler, whereas 28 (44.4%) patients used a 23 mm stapler. No significant differences were observed between the groups. The incidence of anastomotic leakage did not differ significantly between the groups (5.7% vs. 7.1%, p = 1.00) Also, the incidence of anastomotic stenosis did not differ between the groups (25.7% vs. 21.4%, p = 0.77). However, in QOL assessment, the meal‐related subscale (SS) score in the 21 mm group was significantly worse than in the 23 mm group ( p = 0.02). Regarding the details the meal‐related SS score, the feeling of dysphagia was significantly worse in the 21 mm group ( p < 0.01). Conclusions: Short‐term outcomes did not differ between patients who underwent anastomosis with a 21 mm stapler and those with a 23 mm stapler, however QOL, particularly the feeling of dysphagia, was worse in patients who used a 21 mm stapler compared to those who used a 23 mm stapler.

  • Open Access

    Relationship Between Kyphosis and Postoperative Gastroesophageal Reflux After Proximal Gastrectomy

    by Takaomi Ozawa, Suguru Maruyama, Katsutoshi Shoda, Yoshihiko Kawaguchi, Ryo Saito, Kensuke Shiraishi, Shinji Furuya, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

    Aim: The prevalence of kyphosis is increasing with increasing life expectancy. One of the most notable gastrointestinal complications is gastroesophageal reflux disease (GERD) in patients with kyphosis. In this study, we investigated the association between kyphosis and the incidence of postoperative GERD in patients who underwent proximal gastrectomy (PG), a procedure with a particularly high risk of GERD.Methods: In total, 54 consecutive patients who underwent PG between 2009 and 2023 met the inclusion criteria. The thoracic/lumbar angle ratio (T/L ratio) derived from sagittal computed tomography was performed to preoperatively assess kyphosis, defined as a T/L ratio ≥ 1.25.Results: Fifteen patients (27.8%) had kyphosis. Overall, postoperative GERD occurred in seven patients (13.0%). Preoperative albumin levels were significantly lower in the Kyphosis group than in the Normal group (p = 0.03), whereas other clinical characteristics showed no significant differences between the two groups. The incidence of postoperative GERD was significantly higher in the Kyphosis group than in the Normal group (33.3% vs. 5.1%, p = 0.01). Postoperative reflux symptoms also were more frequently observed in the Kyphosis group than in the Normal group (60.0% vs. 16.0%, p = 0.13). Kyphosis was one of the independent predictive factors for postoperative GERD (Odds ratio, 18.7; 95% confidence interval, 1.46–240; p = 0.02) in the multivariate analysis.Conclusion: Kyphosis was significantly associated with the occurrence of postoperative GERD in patients who underwent PG. Alternative preventive measures may be considered when patients with kyphosis undergo PG.


  • Open Access

    Intraoperative indocyanine green fluorescence for precise resection of nonocclusive mesenteric ischemia: a case report and diagnostic considerations based on pathology findings

    by Akihito Mizukami, Shinji Furuya, Koichi Takiguchi, Kensuke Shiraishi, Yuki Nakata, Hidenori Akaike, Yoshihiko Kawaguchi, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

    Background: Nonocclusive mesenteric ischemia (NOMI) is characterized by intestinal ischemia caused by spasms in the peripheral intestinal vessels without organic obstruction in the main mesenteric vessels. NOMI can be fatal in case of delayed diagnosis and treatment. Although the use of indocyanine green (ICG) fluorescence in assessing intestinal viability during NOMI surgery is well recognized, there is a paucity of reported cases using this technique. Herein, we present a case of NOMI that was successfully managed through accurate diagnosis and resection of the ischemic intestines guided by ICG fluorescence. Case presentation: An 81-year-old man presented with abdominal pain. Contrast-enhanced computed tomography revealed intrahepatic portal vein gas, superior mesenteric vein gas, and terminal ileal edema. Considering these findings, the patient was diagnosed with NOMI and emergency surgery was performed. Intestinal edema was observed 30 cm upstream of the terminal ileum without serosal discoloration. ICG fluorescence revealed areas of normal perfusion as well as mild and moderate hypoperfusion. The small bowel, including the hypoperfusion area, was resected. As no clinical signs of residual bowel ischemia were observed during the postoperative course, a second-look operation was deemed unnecessary. Intraoperative ICG fluorescence and histopathological findings indicated mucosal edema in the mildly hypoperfused area and mucosal necrosis in the moderately hypoperfused area. Conclusions: This case highlights the use of intraoperative ICG fluorescence in the disease. ICG fluorescence is invaluable in assessing the extent of bowel ischemia and guiding precise resection. Thus, future efforts should focus on identifying accumulation of cases and quantification of ICG fluorescence intensity to further improve diagnostic performance.


  • Open Access

    Intraluminal washout in rectal and sigmoid colon cancer surgeries with double‐stapling technique anastomosis: A single‐institution prospective study

    by Shinji Furuya, Kensuke Shiraishi, Hiroki Shimizu, Koichi Takiguchi, Makoto Sudo, Akaike Hidenori, Yoshihiko Kawaguchi, Hidetake Amemiya, Tetsuo Kondo, Daisuke Ichikawa

    Aim: This study aimed to determine the necessity of intraluminal washout through cytological assessment to prevent implantation of exfoliated cancer cells (ECCs) in patients with rectal and sigmoid cancers.Methods: We studied 140 patients with either sigmoid or rectal cancer who underwent anastomosis surgery using a double‐stapling technique. An intraluminal washout sample was collected before and after irrigation with 1000, 1500, or 2000 mL of physiological saline or distilled water. Cytological assessments were conducted using the Papanicolaou classification system, where classes IV and V indicated positive cytological findings.Results: Initially, 46.4% of the patients (65 out of 140) had positive ECCs. Patients with cancer cells had a significantly shorter distal free margin (DM) from the tumor (p < 0.001). The length of the DM was significantly associated with the tumor distance from the anal verge (p < 0.001). After irrigation with 2000 mL, ECCs were found in only 7.3% of patients. Logistic regression analysis showed that DM (≤50 mm) and tumor size (≥50 mm) were independent risk factors for positive ECCs after intraluminal washout, regardless of the type of irrigation solution used.Conclusion: In patients with sigmoid colon cancer, adequate preoperative bowel preparation, a long DM, and a small tumor size, a 1000 mL intraluminal washout may be sufficient. By contrast, in patients with rectal cancer with a short DM and a large tumor size, a ≥2000 mL intraluminal washout is required. The different types of irrigation solution did not affect the ECCs. Large randomized controlled trials are required to confirm these results.


  • Investigating Cytoglobin Expression in Colon Cancer: Clinicopathological Insights from Immunohistochemical Analysis

    by Takashi Nakayama, Shinji Furuya, Yudai Higuchi, Koichi Matsuoka, Ryo Saito, Kazunori Takahashi, Suguru Maruyama, Koichi Takiguchi, Katsutoshi Shoda, Yuko Nakayama, et al.

    Background/Aim: Cytoglobin (Cygb), a protein involved in cellular oxygen metabolism and protection, has garnered attention owing to its potential role in the initiation and progression of cancer, particularly colon cancer (CC). This study investigated the expression and significance of Cygb in CC. Patients and Methods: This study included 145 patients who underwent R0 surgery for CC (clinical stage II/III) at our institution between January 2007 and December 2014. Immunohistochemical analysis was performed to evaluate the Cygb expression patterns in CC tissues. Additionally, the correlation between Cygb expression levels and the clinicopathological characteristics of patients with CC was investigated. Results: Colon cancer tissues were categorized into high-expression (95 cases) and low-expression (50 cases) groups. Cygb was highly expressed in well-differentiated cases, whereas its expression decreased in poorly differentiated cases. No significant differences in other clinicopathological factors were observed between the two groups. Cygb expression had no significant effect on recurrence-free survival or overall survival. Conclusion: This study contributes to the growing understanding of Cygb expression and its significance in CC. The expression of Cygb in CC was found to be unrelated to the recurrence rate and prognosis, but showed a correlation with differentiation status.

  • Prognostic effect of sarcopenia in colorectal cancer recurrence

    by Koichi Takiguchi, Shinji Furuya, Makoto Sudo, Ryo Saito, Atsushi Yamamoto, Naoki Ashizawa, Kazuyoshi Hirayama, Katsutoshi Shoda, Hidenori Akaike, Naohiro Hosomura, et al.